Lalimentation de lide mlanote Ce poisson est un carnivore
STEP-HFpEF Trials and Study Design The STEP-HFpEF and STEP-HFpEF DM trials evaluated once-weekly semaglutide treatment versus placebo in patients with obesity-related HFpEF, without and with diabetes, respectively
Benedetti MS, Whomsley R, Poggesi I, Cawello W, Mathy FX, Delporte ML et al (2009) Drug metabolism and pharmacokinetics
After six months of empagliflozin treatment, the patients glycemic control significantly improved: HbA1c levels decreased from 7.4% to 6.2% and TIR increased from 61% to 91%
No representations or claims are made regarding therapeutic intent, clinical relevance, or suitability for human or veterinary use